MTOR and neoplastic disease or syndrome: Since the dysregulation of the mTOR pathway is implicated in several diseases (in particular neoplastic disorders), mTOR inhibitors, such as rapamycin and rapamycin analogs (rapalogs), exhibit a number of useful actions.